[1] Yan R, Sun M, Yang H, et al. 2024 latest report on hepatitis B virus epidemiology in China: current status,changing trajectory,and challenges[J]. Hepatobiliary Surg Nutr,2025, 14(1): 66-77.
[2] Xu Y,Xia C,Li H,et al. Survey of hepatitis B virus infection for liver cancer screening in China: a population-based,cross-sectional study[J]. Chin Med J (Engl),2024,137(12): 1414-1420.
[3] Meng Z,Ma Z,Zhang E,et al. Novel woodchuck hepatitis virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins[J]. J Virol,2014,88(3): 1573-1581.
[4] 徐小倩,王皓,单姗,等.中国慢性乙型肝炎临床特征和抗病毒治疗模式十年变迁:基于CR-HepB的真实世界研究[J]. 中华肝脏病杂志,2023,31(7) : 698-704.
[5] Han B,Zheng R,Zeng H,et al. Cancer incidence and mortality in China,2022[J]. J Natl Cancer Cent,2024,4(1): 47-53.
[6] Graham S,MacLachlan J H,Gunaratnam P,et al. Chronic hepatitis B prevalence in Australian aboriginal and torres strait islander people before and after implementing a universal vaccination program: a systematic review and meta-analysis[J]. Sex Health,2019,16(3): 201-211.
[7] Wu X N,Xue F,Zhang N,et al. Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019[J]. BMC Public Health,2024,24: 363.
[8] 张希,杨雷,刘硕,等 . 2022全球恶性肿瘤统计报告解读[J]. 中华肿瘤杂志 ,2024,46(7):710-721.
[9] 中华医学会肝病学分会,中华医学会感染病学分会 .慢性乙型肝炎防治指南(2022年版)[J].中华肝脏病杂志,2022,30(12):1309-1331.
[10] Dou D R,Zhao Y,Belk J A,et al. Xist ribonucleoproteins promote female sex-biased autoimmunity[J]. Cell,2024,187(3): 733-749.e16.
[11] Kido T,Lo R C lam,Li Y,et al. The potential contributions of a Y-located protooncogene and its X homologue in sexual dimorphisms in hepatocellular carcinoma[J]. Hum Pathol,2014,45(9): 1847-1858.
[12] Xie J,Ding Y,Li X,et al. Association of ESR1 gene polymorphisms with the susceptibility to Hepatitis B virus infection and the clinical outcomes[J]. J Med Virol,2023,95(2): e28510.
[13] Xu B Y,Tan W T,Tan S,et al. Serum testosterone levels and androgen receptor CAG polymorphism correlate with hepatitis B virus (HBV)-related acute liver failure in male HBV carriers[J]. PLoS One,2013,8(12): e84213.
[14] Duan H,Wang X,Qi W,et al. Two genetic variants in the SRD5A2 gene are found to be associated with sex differences in the disease characteristics of patients with chronic hepatitis B virus infection[J]. Biol Sex Differ,2023,4(1): 68.
[15] Park H J,Choi J M. Sex-specific regulation of immune responses by PPARs[J]. Exp Mol Med, 2017,49(8): e364.
[16] Li M,Zhao Y,Chen X,et al. Contribution of sexbased immunological differences to the enhanced immune response in female mice following vaccination with hepatitis B vaccine[J]. Mol Med Rep,2019.
[17] Klein S L. Sex influences immune responses to viruses,and efficacy of prophylaxis and treatments for viral diseases[J]. BioEssays,2012,34(12): 1050-1059.
[18] Spolarics Z,Peña G,Qin Y,et al. Inherent X-linked genetic variability and cellular mosaicism unique to females contribute to sex-related differences in the innate immune response[J]. Front Immunol,2017,8: 1455.
[19] Kosinska A D,Pishraft-Sabet L,Wu W,et al. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models[J]. Hepatology,2017, 66(1): 69-83.
[20] Naugler W E,Sakurai T,Kim S,et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production[J]. Science,2007,317(5834): 121-124.
[21] Gandhi N,Oturkar C C,Das G M. Estrogen receptor-alpha and p53 status as regulators of AMPK and mTOR in luminal breast cancer[J]. Cancers (Basel),2021,13(14): 3612.
[22] Trigunaite A,Dimo J,Jørgensen T N. Suppressive effects of androgens on the immune system[J]. Cell Immunol,2015,294(2): 87-94.
[23] Zhou J,Liu M,Sun H,et al. Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy[J]. Gut,2018,67(5): 931-944.
[24] Shi L,Lin H,Li G,et al. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals[J]. Cancer lett,2016,373(1): 45-56.
[25] Li J,Gao Z,Bai H,et al. Global,regional,and national total burden related to hepatitis B in children and adolescents from 1990 to 2021[J]. BMC Public Health,2024,24: 2936.
[26] Simon F R,Fortune J,Iwahashi M,et al. Multihormonal regulation of hepatic sinusoidal ntcp gene expression[J]. Am J Physiol Gastrointest Liver Physiol,2004,287(4): G782-G794.
[27] Shi J,Wang X,Qi W,et al. Association between NTCP hepatic expression and inflammation/fibrosis as well as gender-specific differences in chronic HBV-infected patients[J]. J Med Virol,2024,96(1): e29428.
[28] Qi X,Li W. Unlocking the secrets to human NTCP structure[J]. Innovation (Camb),2022, 3(5): 100294.
[29] Wang S H,Yeh S H,Lin W H,et al. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B[J]. Hepatology,2009,50(5): 1392-1402.
[30] Wang S,Chen P,Yeh S. Gender disparity in chronic hepatitis B: mechanisms of sex hormones[J]. J Gastroenterol Hepatol,2015,30(8): 1237-1245.
[31] Park E S,Won J,Ahn S H,et al. Gender-specific alteration of steroid metabolism and its impact on viral replication in a mouse model of hepatitis B virus infection[J]. Anim Cells Syst (Seoul),2024,28(1): 466-480.
[32] Wang S,Yeh S,Lin W,et al. Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α[J]. Gastroenterology,2012,142(4): 989-998.e4.
[33] O’Brien M H,Pitot H C,Chung S H,et al. Estrogen receptor-α suppresses liver carcinogenesis and establishes sex-specific gene expression[J]. Cancers (Basel),2021,13(10): 2355.
[34] Yu Y Y,Li J,Wang W X,et al. Research progress on new drugs for the treatment of chronic hepatitis B virus infection.[J]. Zhonghua Gan Zang Bing Za Zhi,2025,33(5): 493-499.
[35] Lugassy C,Bernuau J,Thiers V,et al. Sequences of hepatitis B virus DNA in the serum and liver of patients with acute benign and fulminant hepatitis[J]. J Infect Dis,1987,155(1): 64-71.
[36] Larsson S B,Tripodi G,Raimondo G,et al. Integration of hepatitis B virus DNA in chronically infected patients assessed by Alu-PCR[J]. J Med Virol,2018,90(10): 1568-1575.
[37] Hui R W H,Wong D K H,Lyu X,et al. Profiles of HBV DNA integration in humans with hepatitis B virus infection: insights for antiviral treatment[J]. JHEP Rep,2025,7(9):101487.
[38] 高田敬,韩耕愚,鲁凤民. 核苷(酸)类药物治疗慢性乙型肝炎患者病毒DNA阴转后发生肝细胞癌的相关机制[J]. 中华肝脏病杂志,2019,27(11): 905-909.
[39] Zhao L H,Liu X,Yan H X,et al. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma[J]. Nat Commun,2016,7(1): 12992.
[40] Liu W H,Yeh S H,Chen P J. Role of microRNAs in hepatitis B virus replication and pathogenesis[J]. Biochim Biophys Acta,2011,1809(11-12): 678-685.
[41] Li C,Yeh K,Liu W,et al. Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma[J]. Int J Cancer, 2015,136(4): 761-770.
[42] Jiang R,Deng L,Zhao L,et al. miR-22 promotes HBV-related hepatocellular carcinoma development in males[J]. Clin Cancer Res,2011,17(17): 5593-5603.
[43] Chen P J,Yeh S H,Liu W H,et al. Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis[J]. Hepatology,2012,56(2): 632-643.
[44] Ouyang X,Feng L,Liu G,et al. Androgen receptor (AR) decreases HCC cells migration and invasion via miR-325/ACP5 signaling[J]. J Cancer,2021,12(7): 1915-1925.
[45] Sartorius K,Wang Y,Sartorius B,et al. The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis[J]. Funct Integr Genomics,2025,25(1): 24.
[46] Liu M,Zhao T,Zhang Y,et al. The incidence of hepatocellular carcinoma and clearance of hepatitis B surface for CHB patients in the indeterminate phase: a systematic review and meta-analysis[J]. Front Cell Infect Microbiol,2023,13: 1226755.
[47] Shi L,Yan P,Liang Y,et al. Circular RNA expression is suppressed by androgen receptor (AR)-regulated adenosine deaminase that acts on RNA (ADAR1) in human hepatocellular carcinoma[J]. Cell Death Dis,2017,8(11): e3171. |
